This article discusses the use of radioactive iodine I-131 for the tre
atment of hyperthyroidism. Patient selection involves physiological an
d clinical factors, and physician and patient preference, because surg
ery and antithyroid medication are alternative treatment options. Dose
selection remains an area of uncertainty, because it has not been pos
sible, so far, to resolve the tradeoff between efficient, definitive c
ure of hyperthyroidism and a high incidence of post-therapy hypothyroi
dism. The considerations in the use of radioactive iodine in women in
their childbearing years are reviewed. No clear, consistent cause-and-
effect relationship has been proved between medical radioiodine use an
d an increased risk of subsequent cancers.